Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03558139 |
| Title | A Trial of Hu5F9-G4 With Avelumab in Ovarian Cancer |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Forty Seven, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of Chicago | Chicago | Illinois | 60637 | United States | Details | |
| START Midwest | Grand Rapids | Michigan | 49546 | United States | Details | |
| Oklahoma University Health Sciences Center | Oklahoma City | Oklahoma | 73104 | United States | Details | |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75235 | United States | Details | |
| South Texas Accelerated Research Therapeutics, LLC | San Antonio | Texas | 78229 | United States | Details | |
| University of Washington | Seattle | Washington | 98109 | United States | Details |